Phoenix Stores Refusing COAs
Phoenix-based Story Cannabis has told suppliers that beginning October 1 it will no longer accept products tested by Kaycha Labs or Level One Labs at its 11 Arizona stores. Arizona regulators previously fined Kaycha Labs $88,500 after inspectors found more than a dozen alleged deficiencies involving potency analysis and pesticide and microbial testing; later inspections identified a dilution problem capable of skewing THC results and a failed pesticide test. Level One separately drew regulatory scrutiny this year over potency reporting.
Story CEO Jason Vedadi confirmed the buyer communication, meaning this isn’t a state recall or suspension: a retailer has independently decided that certain COAs are no longer sufficient for shelf access.
Lab shopping and potency inflation have been persistent problems in mature markets, but this is an interesting escalation because the market is imposing a consequence that the regulator hasn’t. Arizona still requires products to pass independent laboratory testing before sale, yet both laboratories remain licensed.
That effectively creates two compliance standards: the state standard required to legally transfer a product, and the retailer’s internal standard required to actually sell it.
This could become a meaningful supply-chain control. If large retail groups begin maintaining their own approved or prohibited laboratory lists, manufacturers may have to consider the testing laboratory almost like another vendor credential. A technically valid COA may no longer guarantee commercial acceptance.
